Publicaciones en 2022
Berard E, Rollig C, Bertoli S, Pigneux A, Tavitian S, Kramer M, Serve H, Bornhauser M, Platzbecker U, Muller-Tidow C, Baldus CD, Martinez-Cuadron D, Serrano J, Martinez-Sanchez P, Arboli ER, Gil C, Bergua J, Bernal T, Burguera AD, Delabesse E, Bidet A, Dumas PY, Montesinos P, Recher C. BLOOD CANCER JOURNAL. 2022. DOI: 10.1038/s41408-022-00700-x
Hernandez-Boluda JC, Martinez-Cuadron D, Pereira A, Rodriguez-Veiga R, Boluda B, Gil C, Casal-Marini S, Serrano J, Martinez-Lopez J, Bergua J, Algarra L, Bernal T, Lopez-Lorenzo JL, Colorado M, Lopez A, Tormo M, Sayas MJ, Trigo F, Lopez-Pavia M, Perez-Simon JA, Lavilla-Rubira E, Rodriguez-Medina C, Rodriguez-Gutierrez JI, Sanz-Caballer MA, Montesinos P. LEUKEMIA RESEARCH. 2022. DOI: 10.1016/j.leukres.2022.106821
Gutierrez A, Bento L, Novelli S, Martin A, Gutierrez G, Salas MQ, Bastos-Oreiro M, Perez A, Hernani R, Viguria MC, Lopez-Godino O, Montoro J, Pinana J, Ferra C, Parody R, Martin C, Espanol I, Yanez L, Rodriguez G, Zanabili J, Herrera P, Varela M, Sampol A, Solano C, Caballero D. CANCERS. 2022. DOI: 10.3390/cancers14112673
Gonzalez-Manzanares R, Castillo JC, Molina JR, Ruiz-Ortiz M, Mesa D, Ojeda S, Anguita M, Pan M. CANCERS. 2022. DOI: 10.3390/cancers14061513
Labrador J, Martinez-Cuadron D, de la Fuente A, Rodriguez-Veiga R, Serrano J, Tormo M, Rodriguez-Arboli E, Ramos F, Bernal T, Lopez-Pavia M, Trigo F, Martinez-Sanchez MP, Rodriguez-Gutierrez JI, Rodriguez-Medina C, Gil C, Belmonte DG, Vives S, Foncillas MA, Perez-Encinas M, Novo A, Recio I, Rodriguez-Macias G, Bergua JM, Noriega V, Lavilla E, Roldan-Perez A, Sanz MA, Montesinos P. CANCERS. 2022. DOI: 10.3390/cancers14092342
Martinez-Cuadron D, Serrano J, Mariz J, Gil C, Tormo M, Martinez-Sanchez P, Rodriguez-Arboli E, Garcia-Boyero R, Rodriguez-Medina C, Martinez-Chamorro C, Polo M, Bergua J, Aguiar E, Amigo ML, Herrera P, Alonso-Dominguez JM, Bernal T, Espadana A, Sayas MJ, Algarra L, Vidriales MB, Vasconcelos G, Vives S, Perez-Encinas MM, Lopez A, Noriega V, Garcia-Fortes M, Chillon MC, Rodriguez-Gutierrez JI, Calasanz MJ, Labrador J, Lopez JA, Boluda B, Rodriguez-Veiga R, Martinez-Lopez J, Barragan E, Sanz MA, Montesinos P. CANCERS. 2022. DOI: 10.3390/cancers14112817
Albasanz-Puig A, Dura-Miralles X, Laporte-Amargos J, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo JM, Mikulska M, Martin-Davila P, Herrera F, Gasch O, Drgona L, Morales HMP, Brunel AS, Garcia E, Isler B, Kern WV, Retamar-Gentil P, Aguado JM, Montero M, Kanj SS, Sipahi OR, Calik S, Marquez-Gomez I, Marin JI, Gomes MZR, Hemmati P, Araos R, Peghin M, del Pozo JL, Yanez L, Tilley R, Manzur A, Novo A, Pallares N, Bergas A, Carratala J, Gudiol C. MICROORGANISMS. 2022. DOI: 10.3390/microorganisms10040733
Gomez VG, Regano LD, Villa AR, Rubio CD, Vicent MG, Serra IB, Fernandez JM, Martinez AIP, Hurtado JMP, Duarte ML, Regalado MSM, Perez-Martinez A. ANALES DE PEDIATRIA. 2022. DOI: 10.1016/j.anpedi.2021.02.015
Lopez JS, Jimenez-Jimenez C, Chutipongtanate S, Serrano J, Rodriguez-Moreno M, Jimenez A, Jimenez Y, Pedrero SG, Lainez D, Alonso-Dominguez JM, Sillero PL, Piris MA, Sanchez-Garcia J. LEUKEMIA & LYMPHOMA. 2022. DOI: 10.1080/10428194.2022.2056173
Sancho JM, Marin-Niebla A, Fernandez S, Capote FJ, Canigral C, Grande C, Donato E, Zeberio I, Puerta JM, Rivas A, Perez-Ceballos E, Vale A, Garcia-Sancho AM, Salar A, Gonzalez-Barca E, Teruel A, Pastoriza C, Conde-Royo D, Sanchez-Garcia J, Barrenetxea C, Arranz R, Hernandez-Rivas JA, Ramirez MJ, Jimenez A, Rubio-Azpeitia E. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2022. DOI: 10.1007/s12185-022-03367-z
Ayala R, Carreno-Tarragona G, Barragan E, Boluda B, Larrayoz MJ, Chillon MC, Carrillo-Cruz E, Bilbao C, Sanchez-Garcia J, Bernal T, Martinez-Cuadron D, Gil C, Serrano J, Rodriguez-Medina C, Bergua J, Perez-Simon JA, Calbacho M, Alonso-Dominguez JM, Labrador J, Tormo M, Amigo ML, Herrera-Puente P, Rapado I, Sargas C, Vazquez I, Calasanz MJ, Gomez-Casares T, Garcia-Sanz R, Sanz MA, Martinez-Lopez J, Montesinos P. CANCERS. 2022. DOI: 10.3390/cancers14235799
Recher C, Rollig C, Berard E, Bertoli S, Dumas PY, Tavitian S, Kramer M, Serve H, Bornhauser M, Platzbecker U, Muller-Tidow C, Baldus CD, Martinez-Cuadron D, Serrano J, Martinez-Sanchez P, Arboli ER, Gil C, Bergua J, Bernal T, Burguera AD, Delabesse E, Bidet A, Pigneux A, Montesinos P. LEUKEMIA. 2022. DOI: 10.1038/s41375-021-01425-9
Macias-Sanchez MD, Morata-Tarifa C, Cuende N, Cardesa-Gil A, Cuesta-Casas MA, Pascual-Cascon MJ, Pascual A, Martin-Calvo C, Jurado M, Perez-Simon JA, Espigado I, Lopez SG, Sanchez GC, Mata-Alcazar-Caballero R, Sanchez-Pernaute R. STEM CELLS TRANSLATIONAL MEDICINE. 2022. DOI: 10.1093/stcltm/szac003
Castano-Bonilla T, Barragan E, Sargas C, Sanz A, Algarra L, Herrera-Puente P, Garcia-Boyero R, Barrios M, Martinez-Cuadron D, Rodriguez-Veiga R, Boluda B, Gil C, Serrano-Lopez J, Martinez-Lopez J, Sayas-Lloris MJ, Olave MT, Riaza-Grau R, Bernal-Del Castillo T, Larrayoz MJ, Amigo R, Jimenez-Velasco A, Sanchez J, Ayala R, Blas C, Lainez D, Serrano-Lopez J, Sanz MA, Alonso-Dominguez JM, Montesinos P. DISEASE MARKERS. 2022. DOI: 10.1155/2022/3132941
Vilorio-Marques L, Fernandez CC, Mora E, Gutierrez L, Bua BR, Lorenzo MJJ, Beya MD, Pampliega MV, Molero A, Sanchez-Garcia J, Calabuig M, Cedena MT, Chen-Liang T, Santa JAD, Padilla I, Hernandez F, Diez R, Asensi P, Xicoy B, Sanz G, Valcarcel D, Diez-Campelo M, Bernal T. THERAPEUTIC ADVANCES IN HEMATOLOGY. 2022. DOI: 10.1177/20406207221127547
Chumbita M, Puerta-Alcalde P, Yanez L, Cuesta MA, Chinea A, Morales IE, Abellan PF, Gudiol C, Guerreiro M, Gonzalez-Sierra P, Rojas R, Pina JMS, Vadillo IS, Varela R, Vazquez L, Lopera C, Monzo P, Garcia-Vidal C. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022. DOI: 10.1093/jac/dkac135
Villar S, Ariceta B, Agirre X, Urribarri AD, Ayala R, Martinez-Cuadron D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Simoes C, Herrera P, Calasanz MJ, Alfonso-Pierola A, Paiva B, Martinez-Lopez J, San Miguel JF, Prosper F, Montesinos P. FRONTIERS IN ONCOLOGY. 2022. DOI: 10.3389/fonc.2022.1054458
Martinez-Cuadron D, Megias-Vericat JE, Serrano J, Martinez-Sanchez P, Rodriguez-Arboli E, Gil C, Aguiar E, Bergua J, Lopez-Lorenzo JL, Bernal T, Espadana A, Colorado M, Rodriguez-Medina C, Lopez-Pavia M, Tormo M, Algarra L, Amigo ML, Sayas MJ, Labrador J, Rodriguez-Gutierrez JI, Benavente C, Costilla-Barriga L, Garcia-Boyero R, Lavilla-Rubira E, Vives S, Herrera P, Garcia-Belmonte D, Herraez MM, Esteves GV, Gomez-Roncero MI, Cabello A, Bautista G, Balerdi A, Mariz J, Boluda B, Sanz MA, Montesinos P. BLOOD ADVANCES. 2022. DOI: 10.1182/bloodadvances.2021005335
Ruiz-Llobet A, Gassiot S, Sarrate E, Zubicaray J, Dapena JL, Rives S, Sevilla J, Lopez AM, Romero MP, Montoya C, Vagace JM, Hurtado JRM, Garcia-Morin M, Abos MG, Sanchez MCM, Lendinez F, Moraleda PP, Tallon M, Gonzalez B, Urrutia E, Serna JV, Pleguezuelos IP, Merino MM, Elbal ER, Orellana E, Munoz HB, Berrueco R. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2022. DOI: 10.1111/jth.15699
Publications in 2021
Perez-Sanchez L, Patino-Trives AM, Aguirre-Zamorano MA, Luque-Tevar M, Abalos-Aguilera MC, Arias-de La Rosa I, Segui P, Velasco-Gimena F, Barbarroja N, Escudero-Contreras A, Collantes-Estevez E, Perez-Sanchez C, Lopez-Pedrera C. Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 202 41(2):865-877. DOI: 10.1161/ATVBAHA.120.315346.
IF: 8,311 Q1 D1
Vives S, Martinez-Cuadron D, Burgues JB, Algarra L, Tormo M, Martinez-Sanchez MP, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Lopez-Lorenzo JL, Gil C, Vidriales B, Falantes JF, Serrano A, Labrador J, Sayas MJ, Foncillas MA, Barciela MLA, Olave MT, Colorado M, Gascon A, Fernandez MA, Simiele A, Perez-Encinas MM, Rodriguez-Veiga R, Garcia O, Martinez-Lopez J, Barragan E, Paiva B, Sanz MA, Montesinos P. A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia. CANCER. 2021. 127(12):2003-2014. DOI: 10.1002/cncr.33403.
IF: 6,86 Q1 D2
Bento L, Gutierrez A, Novelli S, Montoro J, Pinana JL, Lopez-Corral L, Cabrero M, Martin-Sancho A, Gutierrez-Garcia G, Ortiz-Moscovich M, Bastos-Oreiro M, Dorado N, Perez A, Hernani R, Ferra C, Parody R, Garcia-Cadenas I, Herrera P, Rodriguez G, Rodriguez N, Martin C, Yanez L, Zanabili J, Varela MR, Lopez-Godino O, Heras I, Espanol I, Martinez C, Perez-Simon JA, Solano C, Sureda A, Sierra J, Sampol A, Caballero D. Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study. BONE MARROW TRANSPLANTATION. 2021. 56(8):1919-1928. DOI: 10.1038/s41409-021-01264-
IF: 5,483 Q1 D3
Palanques-Pastor T, Megias-Vericat JE, Martinez P, Lorenzo JLL, Navascues JC, Macias GR, Cano I, Sangerman MA, Vicente MBV, Algarra JLA, Foncillas MA, Herrera P, Prieto CB, Vives S, Alvarez AF, Palomares LC, Sobas M, Gonzalo AC, Garcia RC, Diez MEA, Llorente DD, Elorza BN, Burgues JMB, Del Castillo TB, Rodriguez MCM, Lopez ED, Villegas ACF, Boyero RG, Escobar CE, Merino CS, Cervero C, Perez AR, Ramos LH, Calvo MC, Olave MT, Gutierrez PV, de Laiglesiai A, Serrano J, Irazu MJN, Pinana JL, Sanz MA, Martinez-Lopez J, Montesinos P. Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group. LEUKEMIA & LYMPHOMA. 2021. 62(12):2928-2938. DOI: 10.1080/10428192021.1948031.
IF: 3,28 Q3
Ribera JM, Morgades M, Ciudad J, Montesinos P, Esteve J, Genesca E, Barba P, Ribera J, Garcia-Cadenas I, Moreno MJ, Martinez-Carballeira D, Torrent A, Martinez-Sanchez P, Monsalvo S, Gil C, Tormo M, Artola MT, Cervera M, Gonzalez-Campos J, Rodriguez C, Bermudez A, Novo A, Soria B, Coll R, Amigo ML, Lopez-Martinez A, Fernandez-Martin R, Serrano J, Mercadal S, Cladera A, Gimenez-Conca A, Penarrubia MJ, Abella E, Vall-llovera F, Hernandez-Rivas JM, Garcia-Guinon A, Bergua JM, de Rueda B, Sanchez-Sanchez MJ, Serrano A, Calbacho M, Alonso N, Mendez-Sanchez JA, Garcia-Boyero R, Olivares M, Barrena S, Zamora L, Granada I, Lhermitte L, Feliu E, Orfao A. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia. BLOOD. 2021. 137(14):1879-1894. DOI: 10.1182/blood.2020007311.
IF: 22,113 Q1 D1
Rodriguez-Pinilla SM, Domingo-Domenech E, Climent F, Sanchez J, Seoane CP, Jimenez JL, Garcia-Cosio M, Caballero D, Munez OJB, Carpio C, Castellvi J, Pozo AM, Farre BG, Bendana A, Aliste C, Gonzalez AJ, de Villambrosia SG, Piris MA, Codina JG, Mayordomo-Aranda E, Navarro B, Bellas C, Rodriguez G, Borrero JJ, Ruiz-Zorrilla A, Grande M, Montoto C, Cordoba R. Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study. BRITISH JOURNAL OF HAEMATOLOGY. 2021. 192(1):82-99. DOI: 10.1111/bjh.16741.
IF: 6,998 Q1 D2
Solano C, Vazquez L, Gimenez E, de la Camara R, Albert E, Rovira M, Espigado I, Calvo CM, Lopez-Jimenez J, Suarez-Lledo M, Chinea A, Esquirol A, Perez A, Bermudez A, Saldana R, Heras I, Gonzalez-Huerta AJ, Torrado T, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta MA, Pinana JL, Navarro D. Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment. BONE MARROW TRANSPLANTATION. 2021. 56(6):1281-1290. DOI: 10.1038/s41409-020-01157-x.
IF: 5,483 Q1 D3
Janusz K, Izquierdo MM, Cadenas FL, Ramos F, Sanchez JMH, Lumbreras E, Robledo C, del Real JS, Caballero JC, Collado R, Bernal T, Pedro C, Insunza A, de Paz R, Xicoy B, Salido E, Garcia JS, Minguez SS, Garcia CM, Munoz AMS, Barba MS, Rivas JMH, Abaigar M, Campelo MD. Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients. ANNALS OF HEMATOLOGY. 2021. 100(8):1995-2004. DOI: 10.1007/s00277-020-04360-4.
IF: 3,673 Q2 D5
Rodriguez DC, Urain TA, Rodriguez AC, Torres EG, Vicent MG, Garcia GG, Garcia AR, Hidalgo MC, Villacampa A. Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain. JOURNAL OF MEDICAL ECONOMICS. 2021. 24(1):628-636. DOI: 10.1080/13696998.2021.191674
IF: 2,448 Q2 D5
Vicent MG, de Heredia CD, de Pablo JG, Molina B, Regueiro A, Martinez AP, Palomo P, Corral LL, Garcia E, Fernandez JM, Perez A, Jimenez MJ, Guerreiro M, Vallejo C, Gallardo AI, Lopez O, Benito A, Marsal J, Duarte M, Bento L, Badell I, Pedraza A, Ubieto AJ, Gonzalez P, Centurion IG, Costilla L, Belendez C, Esquirol A, Espigado I, Lavilla E, Diaz MA. Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH). EUROPEAN JOURNAL OF HAEMATOLOGY. 2021. 106(6):842-850. DOI: 1111/ejh.13618. IF: 2,997 Q3
Martinez-Cuadron D, Serrano J, Gil C, Tormo M, Martinez-Sanchez P, Perez-Simon JA, Garcia-Boyero R, Rodriguez-Medina C, Lopez-Pavia M, Benavente C, Bergua J, Lavilla-Rubira E, Amigo ML, Herrera P, Alonso-Dominguez JM, Bernal T, Colorado M, Sayas MJ, Algarra L, Vidriales MB, Rodriguez-Macias G, Vives S, Perez-Encinas MM, Lopez A, Noriega V, Garcia-Fortes M, Ramos F, Rodriguez-Gutierrez JI, Costilla-Barriga L, Labrador J, Boluda B, Rodriguez-Veiga R, Martinez-Lopez J, Sanz MA, Montesinos P. Evolving treatment patterns and outcomes in older patients (>= 60 years) with AML: changing everything to change nothing?. LEUKEMIA. 2021. 35(6):1571-1585. DOI: 10.1038/s41375-020-01058-4.
IF: 11,528 Q1 D1
Paiva B, Vidriales MB, Sempere A, Tarin F, Colado E, Benavente C, Cedena MT, Sanchez J, Caballero-Velazquez T, Cordon L, Garces JJ, Simoes C, Martinez-Cuadron D, Bernal T, Botella C, Grille S, Serrano J, Rodriguez-Medina C, Algarra L, Alonso-Dominguez JM, Amigo ML, Barrios M, Garcia-Boyero R, Colorado M, Perez-Oteyza J, Perez-Encinas M, Costilla-Barriga L, Sayas MJ, Perez O, Gonzalez-Diaz M, Perez-Simon JA, Martinez-Lopez J, Sossa C, Orfao A, San Miguel JF, Sanz MA, Montesinos P. Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia. LEUKEMIA. 2021. 35(8):2358-2370. DOI: 10.1038/s41375-021-01126-3.
IF: 11,528 Q1 D1
Serrano-Lopez J, Hegde S, Kumar S, Serrano J, Fang J, Wellendorf AM, Roche PA, Rangel Y, Carrington LJ, Geiger H, Grimes HL, Luther S, Maillard I, Sanchez-Garcia J, Starczynowski DT, Cancelas JA. Inflammation rapidly recruits mammalian GMP and MDP from bone marrow into regional lymphatics. ELIFE. 2021. 10():-. DOI: 10.7554/eLife.66190.
IF: 8,14 Q1 D1
Mingot-Castellano ME, Pardos-Gea J, Haya S, Bastida-Bermejo JM, Tassies D, Marco-Rico A, Nunez R, Garcia-Candel F, De Mora MCFS, Soto I, Alvarez-Roman MT, Asenjo S, Carrasco M, Lluch-Garcia R, Martin-Antoran JM, Rodriguez-Alen A, Rosello E, Torres-Minana L, Marcellini-Antonio S, Moreto-Quinana A, Rodriguez-Garcia JA, Aguinaco-Culebras R, Alonso-Escobar N, Cervero-Santiago C, Fernandez-Mosteirin N, Martinez-Badas MP, Perez-Sanchez M, Perez-Montes R, Rodriguez-Gonzalez R, Uribe-Barrientos M, Caparros-Miranda IS, Iglesias-Fernandez M, Baena A, Rodriguez-Lopez M, Sebrango-Sandia A, Vazquez-Fernandez I, Marco P. Management of acquired hemophilia A: results from the Spanish registry. BLOOD ADVANCES. 2021. 5(19):3821-3829. DOI: 10.1182/bloodadvances.2021004626.
IF: 6,799 Q1 D2
Vega-Garcia N, Perez-Jaume S, Esperanza-Cebollada E, Vicente-Garces C, Torrebadell M, Jimenez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sanchez-Garcia J, Garcia-Calderon CB, Gomez-Casares MT, Martin-Clavero E, Escudero A, Martinez-Gallo MR, Munoz L, Velasco MR, Garcia-Morin M, Catala A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molines A, Guerra-Garcia P, Perez-Martinez A, Garcia-Abos M, Ortiz RR, Pisa S, Adan R, de Heredia CD, Dapena JL, Rives S, Ramirez-Orellana M, Camos M. Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment. FRONTIERS IN PEDIATRICS. 2021. 8():-. DOI: 10.3389/fped.2020.614521.
IF: 3,418 Q1 D2
Simoes C, Paiva B, Martinez-Cuadron D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lopez JL, Vidriales MB, Labrador J, Falantes JF, Sayas MJ, Ayala R, Martinez-Lopez J, Villar S, Calasanz MJ, Prosper F, San-Miguel JF, Sanz MA, Montesinos P. Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial. BLOOD ADVANCES. 2021. 5(3):760-770. DOI: 10.1182/bloodadvances.2020003195. IF: 6,686 Q1 D2
Sargas C, Ayala R, Chillon MC, Larrayoz MJ, Carrillo-Cruz E, Bilbao C, Yebenes-Ramirez M, Llop M, Rapado I, Garcia-Sanz R, Vazquez I, Soria E, Florido-Ortega Y, Janusz K, Botella C, Serrano J, Martinez-Cuadron D, Bergua J, Amigo ML, Martinez-Sanchez P, Tormo M, Bernal T, Herrera-Puente P, Garcia R, Algarra L, Sayas MJ, Costilla-Barriga L, Perez-Santolalla E, Marchante I, Lavilla-Rubira E, Noriega V, Alonso-Dominguez JM, Sanz MA, Sanchez-Garcia J, Gomez-Casares MT, Perez-Simon JA, Calasanz MJ, Gonzalez-Diaz M, Martinez-Lopez J, Barragan E, Montesinos P. Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project. HAEMATOLOGICA. 2021. 106(12):3079-3089. DOI: 10.3324/haematol.2020.263806.
IF: 9,941 Q1 D2
Castano-Bonilla T, Alonso-Dominguez JM, Barragan E, Rodriguez-Veiga R, Sargas C, Gil C, Chillon C, Vidriales MB, Garcia R, Martinez-Lopez J, Ayala R, Larrayoz MJ, Anguita E, Cuello R, Cantalapiedra A, Carrillo E, Soria-Saldise E, Labrador J, Recio I, Algarra L, Rodriguez-Medina C, Bilbao-Syeiro C, Lopez-Lopez JA, Serrano J, De Cabo E, Sayas MJ, Olave MT, Sanchez-Garcia J, Mateos M, Blas C, Lopez-Lorenzo JL, Lainez-Gonzalez D, Serrano J, Martinez-Cuadron D, Sanz MA, Montesinos P. Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens. SCIENTIFIC REPORTS. 2021. 11(1):-. DOI: 10.1038/s41598-021-00050-x.
IF: 4,38 Q1 D3
Abrisqueta P, Loscertales J, Terol MJ, Payer AR, Ortiz M, Perez I, Cuellar-Garcia C, de la Mata MF, Rodriguez A, Lario A, Delgado J, Godoy A, Perez JMA, Berruezo MJ, Oliveira A, Hernandez-Rivas JA, Malo MDG, Medina A, Martin PG, Osorio S, Baltasar P, Fernandez-Zarzoso M, Marco F, Mancenido MJV, Simonovich AS, Rubio ML, Jarque I, Suarez A, Alvarez RF, Anchel AL, Rios E, Castillo MDL, Persona EP, Munoz RG, Ramos R, Yanez L, Bello JL, Loriente C, Acha D, Villanueva M. Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study). CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2021. 21(12):E985-E999. DOI: 10.1016/j.clml.2021.07.022.
IF: 3,231 Q3
Murillo-Sanjuan L, Gonzalez-Vicent M, Aparicio BA, Serra IB, Villa AR, Oficialdegui MLU, Lopez-Duarte M, Belendez-Bieler C, Urgelles AS, Navarro JS, Diaz-de-Heredia C. Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children. BONE MARROW TRANSPLANTATION. 2021. 56(5):1213-1216. DOI: 10.1038/s41409-020-01172-y. IF: 5,483 Q1 D3
Ayala R, Rapado I, Onecha E, Martinez-Cuadron D, Carreno-Tarragona G, Bergua JM, Vives S, Algarra JL, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lorenzo JLL, Vidriales MB, Labrador J, Falantes JF, Sayas MJ, Paiva B, Barragan E, Prosper F, Sanz MA, Martinez-Lopez J, Montesinos P. The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial. CANCERS. 20 13(10):-. DOI: 10.3390/cancers13102458.
IF: 6,639 Q1 D3
Publicaciones 2021
Perez-Sanchez L, Patino-Trives AM, Aguirre-Zamorano MA, Luque-Tevar M, Abalos-Aguilera MC, Arias-de La Rosa I, Segui P, Velasco-Gimena F, Barbarroja N, Escudero-Contreras A, Collantes-Estevez E, Perez-Sanchez C, Lopez-Pedrera C. Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 202 41(2):865-877. DOI: 10.1161/ATVBAHA.120.315346.
IF: 8,311 Q1 D1
Vives S, Martinez-Cuadron D, Burgues JB, Algarra L, Tormo M, Martinez-Sanchez MP, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Lopez-Lorenzo JL, Gil C, Vidriales B, Falantes JF, Serrano A, Labrador J, Sayas MJ, Foncillas MA, Barciela MLA, Olave MT, Colorado M, Gascon A, Fernandez MA, Simiele A, Perez-Encinas MM, Rodriguez-Veiga R, Garcia O, Martinez-Lopez J, Barragan E, Paiva B, Sanz MA, Montesinos P. A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia. CANCER. 2021. 127(12):2003-2014. DOI: 10.1002/cncr.33403.
IF: 6,86 Q1 D2
Bento L, Gutierrez A, Novelli S, Montoro J, Pinana JL, Lopez-Corral L, Cabrero M, Martin-Sancho A, Gutierrez-Garcia G, Ortiz-Moscovich M, Bastos-Oreiro M, Dorado N, Perez A, Hernani R, Ferra C, Parody R, Garcia-Cadenas I, Herrera P, Rodriguez G, Rodriguez N, Martin C, Yanez L, Zanabili J, Varela MR, Lopez-Godino O, Heras I, Espanol I, Martinez C, Perez-Simon JA, Solano C, Sureda A, Sierra J, Sampol A, Caballero D. Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study. BONE MARROW TRANSPLANTATION. 2021. 56(8):1919-1928. DOI: 10.1038/s41409-021-01264-
IF: 5,483 Q1 D3
Palanques-Pastor T, Megias-Vericat JE, Martinez P, Lorenzo JLL, Navascues JC, Macias GR, Cano I, Sangerman MA, Vicente MBV, Algarra JLA, Foncillas MA, Herrera P, Prieto CB, Vives S, Alvarez AF, Palomares LC, Sobas M, Gonzalo AC, Garcia RC, Diez MEA, Llorente DD, Elorza BN, Burgues JMB, Del Castillo TB, Rodriguez MCM, Lopez ED, Villegas ACF, Boyero RG, Escobar CE, Merino CS, Cervero C, Perez AR, Ramos LH, Calvo MC, Olave MT, Gutierrez PV, de Laiglesiai A, Serrano J, Irazu MJN, Pinana JL, Sanz MA, Martinez-Lopez J, Montesinos P. Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group. LEUKEMIA & LYMPHOMA. 2021. 62(12):2928-2938. DOI: 10.1080/10428192021.1948031.
IF: 3,28 Q3
Ribera JM, Morgades M, Ciudad J, Montesinos P, Esteve J, Genesca E, Barba P, Ribera J, Garcia-Cadenas I, Moreno MJ, Martinez-Carballeira D, Torrent A, Martinez-Sanchez P, Monsalvo S, Gil C, Tormo M, Artola MT, Cervera M, Gonzalez-Campos J, Rodriguez C, Bermudez A, Novo A, Soria B, Coll R, Amigo ML, Lopez-Martinez A, Fernandez-Martin R, Serrano J, Mercadal S, Cladera A, Gimenez-Conca A, Penarrubia MJ, Abella E, Vall-llovera F, Hernandez-Rivas JM, Garcia-Guinon A, Bergua JM, de Rueda B, Sanchez-Sanchez MJ, Serrano A, Calbacho M, Alonso N, Mendez-Sanchez JA, Garcia-Boyero R, Olivares M, Barrena S, Zamora L, Granada I, Lhermitte L, Feliu E, Orfao A. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia. BLOOD. 2021. 137(14):1879-1894. DOI: 10.1182/blood.2020007311.
IF: 22,113 Q1 D1
Rodriguez-Pinilla SM, Domingo-Domenech E, Climent F, Sanchez J, Seoane CP, Jimenez JL, Garcia-Cosio M, Caballero D, Munez OJB, Carpio C, Castellvi J, Pozo AM, Farre BG, Bendana A, Aliste C, Gonzalez AJ, de Villambrosia SG, Piris MA, Codina JG, Mayordomo-Aranda E, Navarro B, Bellas C, Rodriguez G, Borrero JJ, Ruiz-Zorrilla A, Grande M, Montoto C, Cordoba R. Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study. BRITISH JOURNAL OF HAEMATOLOGY. 2021. 192(1):82-99. DOI: 10.1111/bjh.16741.
IF: 6,998 Q1 D2
Solano C, Vazquez L, Gimenez E, de la Camara R, Albert E, Rovira M, Espigado I, Calvo CM, Lopez-Jimenez J, Suarez-Lledo M, Chinea A, Esquirol A, Perez A, Bermudez A, Saldana R, Heras I, Gonzalez-Huerta AJ, Torrado T, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta MA, Pinana JL, Navarro D. Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment. BONE MARROW TRANSPLANTATION. 2021. 56(6):1281-1290. DOI: 10.1038/s41409-020-01157-x.
IF: 5,483 Q1 D3
Janusz K, Izquierdo MM, Cadenas FL, Ramos F, Sanchez JMH, Lumbreras E, Robledo C, del Real JS, Caballero JC, Collado R, Bernal T, Pedro C, Insunza A, de Paz R, Xicoy B, Salido E, Garcia JS, Minguez SS, Garcia CM, Munoz AMS, Barba MS, Rivas JMH, Abaigar M, Campelo MD. Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients. ANNALS OF HEMATOLOGY. 2021. 100(8):1995-2004. DOI: 10.1007/s00277-020-04360-4.
IF: 3,673 Q2 D5
Rodriguez DC, Urain TA, Rodriguez AC, Torres EG, Vicent MG, Garcia GG, Garcia AR, Hidalgo MC, Villacampa A. Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain. JOURNAL OF MEDICAL ECONOMICS. 2021. 24(1):628-636. DOI: 10.1080/13696998.2021.191674
IF: 2,448 Q2 D5
Vicent MG, de Heredia CD, de Pablo JG, Molina B, Regueiro A, Martinez AP, Palomo P, Corral LL, Garcia E, Fernandez JM, Perez A, Jimenez MJ, Guerreiro M, Vallejo C, Gallardo AI, Lopez O, Benito A, Marsal J, Duarte M, Bento L, Badell I, Pedraza A, Ubieto AJ, Gonzalez P, Centurion IG, Costilla L, Belendez C, Esquirol A, Espigado I, Lavilla E, Diaz MA. Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH). EUROPEAN JOURNAL OF HAEMATOLOGY. 2021. 106(6):842-850. DOI: 1111/ejh.13618. IF: 2,997 Q3
Martinez-Cuadron D, Serrano J, Gil C, Tormo M, Martinez-Sanchez P, Perez-Simon JA, Garcia-Boyero R, Rodriguez-Medina C, Lopez-Pavia M, Benavente C, Bergua J, Lavilla-Rubira E, Amigo ML, Herrera P, Alonso-Dominguez JM, Bernal T, Colorado M, Sayas MJ, Algarra L, Vidriales MB, Rodriguez-Macias G, Vives S, Perez-Encinas MM, Lopez A, Noriega V, Garcia-Fortes M, Ramos F, Rodriguez-Gutierrez JI, Costilla-Barriga L, Labrador J, Boluda B, Rodriguez-Veiga R, Martinez-Lopez J, Sanz MA, Montesinos P. Evolving treatment patterns and outcomes in older patients (>= 60 years) with AML: changing everything to change nothing?. LEUKEMIA. 2021. 35(6):1571-1585. DOI: 10.1038/s41375-020-01058-4.
IF: 11,528 Q1 D1
Paiva B, Vidriales MB, Sempere A, Tarin F, Colado E, Benavente C, Cedena MT, Sanchez J, Caballero-Velazquez T, Cordon L, Garces JJ, Simoes C, Martinez-Cuadron D, Bernal T, Botella C, Grille S, Serrano J, Rodriguez-Medina C, Algarra L, Alonso-Dominguez JM, Amigo ML, Barrios M, Garcia-Boyero R, Colorado M, Perez-Oteyza J, Perez-Encinas M, Costilla-Barriga L, Sayas MJ, Perez O, Gonzalez-Diaz M, Perez-Simon JA, Martinez-Lopez J, Sossa C, Orfao A, San Miguel JF, Sanz MA, Montesinos P. Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia. LEUKEMIA. 2021. 35(8):2358-2370. DOI: 10.1038/s41375-021-01126-3.
IF: 11,528 Q1 D1
Serrano-Lopez J, Hegde S, Kumar S, Serrano J, Fang J, Wellendorf AM, Roche PA, Rangel Y, Carrington LJ, Geiger H, Grimes HL, Luther S, Maillard I, Sanchez-Garcia J, Starczynowski DT, Cancelas JA. Inflammation rapidly recruits mammalian GMP and MDP from bone marrow into regional lymphatics. ELIFE. 2021. 10():-. DOI: 10.7554/eLife.66190.
IF: 8,14 Q1 D1
Mingot-Castellano ME, Pardos-Gea J, Haya S, Bastida-Bermejo JM, Tassies D, Marco-Rico A, Nunez R, Garcia-Candel F, De Mora MCFS, Soto I, Alvarez-Roman MT, Asenjo S, Carrasco M, Lluch-Garcia R, Martin-Antoran JM, Rodriguez-Alen A, Rosello E, Torres-Minana L, Marcellini-Antonio S, Moreto-Quinana A, Rodriguez-Garcia JA, Aguinaco-Culebras R, Alonso-Escobar N, Cervero-Santiago C, Fernandez-Mosteirin N, Martinez-Badas MP, Perez-Sanchez M, Perez-Montes R, Rodriguez-Gonzalez R, Uribe-Barrientos M, Caparros-Miranda IS, Iglesias-Fernandez M, Baena A, Rodriguez-Lopez M, Sebrango-Sandia A, Vazquez-Fernandez I, Marco P. Management of acquired hemophilia A: results from the Spanish registry. BLOOD ADVANCES. 2021. 5(19):3821-3829. DOI: 10.1182/bloodadvances.2021004626.
IF: 6,799 Q1 D2
Vega-Garcia N, Perez-Jaume S, Esperanza-Cebollada E, Vicente-Garces C, Torrebadell M, Jimenez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sanchez-Garcia J, Garcia-Calderon CB, Gomez-Casares MT, Martin-Clavero E, Escudero A, Martinez-Gallo MR, Munoz L, Velasco MR, Garcia-Morin M, Catala A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molines A, Guerra-Garcia P, Perez-Martinez A, Garcia-Abos M, Ortiz RR, Pisa S, Adan R, de Heredia CD, Dapena JL, Rives S, Ramirez-Orellana M, Camos M. Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment. FRONTIERS IN PEDIATRICS. 2021. 8():-. DOI: 10.3389/fped.2020.614521.
IF: 3,418 Q1 D2
Simoes C, Paiva B, Martinez-Cuadron D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lopez JL, Vidriales MB, Labrador J, Falantes JF, Sayas MJ, Ayala R, Martinez-Lopez J, Villar S, Calasanz MJ, Prosper F, San-Miguel JF, Sanz MA, Montesinos P. Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial. BLOOD ADVANCES. 2021. 5(3):760-770. DOI: 10.1182/bloodadvances.2020003195. IF: 6,686 Q1 D2
Sargas C, Ayala R, Chillon MC, Larrayoz MJ, Carrillo-Cruz E, Bilbao C, Yebenes-Ramirez M, Llop M, Rapado I, Garcia-Sanz R, Vazquez I, Soria E, Florido-Ortega Y, Janusz K, Botella C, Serrano J, Martinez-Cuadron D, Bergua J, Amigo ML, Martinez-Sanchez P, Tormo M, Bernal T, Herrera-Puente P, Garcia R, Algarra L, Sayas MJ, Costilla-Barriga L, Perez-Santolalla E, Marchante I, Lavilla-Rubira E, Noriega V, Alonso-Dominguez JM, Sanz MA, Sanchez-Garcia J, Gomez-Casares MT, Perez-Simon JA, Calasanz MJ, Gonzalez-Diaz M, Martinez-Lopez J, Barragan E, Montesinos P. Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project. HAEMATOLOGICA. 2021. 106(12):3079-3089. DOI: 10.3324/haematol.2020.263806.
IF: 9,941 Q1 D2
Castano-Bonilla T, Alonso-Dominguez JM, Barragan E, Rodriguez-Veiga R, Sargas C, Gil C, Chillon C, Vidriales MB, Garcia R, Martinez-Lopez J, Ayala R, Larrayoz MJ, Anguita E, Cuello R, Cantalapiedra A, Carrillo E, Soria-Saldise E, Labrador J, Recio I, Algarra L, Rodriguez-Medina C, Bilbao-Syeiro C, Lopez-Lopez JA, Serrano J, De Cabo E, Sayas MJ, Olave MT, Sanchez-Garcia J, Mateos M, Blas C, Lopez-Lorenzo JL, Lainez-Gonzalez D, Serrano J, Martinez-Cuadron D, Sanz MA, Montesinos P. Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens. SCIENTIFIC REPORTS. 2021. 11(1):-. DOI: 10.1038/s41598-021-00050-x.
IF: 4,38 Q1 D3
Abrisqueta P, Loscertales J, Terol MJ, Payer AR, Ortiz M, Perez I, Cuellar-Garcia C, de la Mata MF, Rodriguez A, Lario A, Delgado J, Godoy A, Perez JMA, Berruezo MJ, Oliveira A, Hernandez-Rivas JA, Malo MDG, Medina A, Martin PG, Osorio S, Baltasar P, Fernandez-Zarzoso M, Marco F, Mancenido MJV, Simonovich AS, Rubio ML, Jarque I, Suarez A, Alvarez RF, Anchel AL, Rios E, Castillo MDL, Persona EP, Munoz RG, Ramos R, Yanez L, Bello JL, Loriente C, Acha D, Villanueva M. Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study). CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2021. 21(12):E985-E999. DOI: 10.1016/j.clml.2021.07.022.
IF: 3,231 Q3
Murillo-Sanjuan L, Gonzalez-Vicent M, Aparicio BA, Serra IB, Villa AR, Oficialdegui MLU, Lopez-Duarte M, Belendez-Bieler C, Urgelles AS, Navarro JS, Diaz-de-Heredia C. Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children. BONE MARROW TRANSPLANTATION. 2021. 56(5):1213-1216. DOI: 10.1038/s41409-020-01172-y. IF: 5,483 Q1 D3
Ayala R, Rapado I, Onecha E, Martinez-Cuadron D, Carreno-Tarragona G, Bergua JM, Vives S, Algarra JL, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lorenzo JLL, Vidriales MB, Labrador J, Falantes JF, Sayas MJ, Paiva B, Barragan E, Prosper F, Sanz MA, Martinez-Lopez J, Montesinos P. The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial. CANCERS. 20 13(10):-. DOI: 10.3390/cancers13102458.
IF: 6,639 Q1 D3
Publicaciones 2020
Sitges M, Boluda B, Garrido A, Morgades M, Granada I, Barragan E, Arnan M, Serrano J, Tormo M, Bergua JM, Colorado M, Salamero O, Esteve J, Benavente C, Perez-Encinas M, Coll R, Marti-Tutusaus JM, Brunet S, Sierra J, Sanz MA, Montesinos P, Ribera JM, Vive. Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols. EUROPEAN JOURNAL OF HAEMATOLOGY. 2020. 105 (2):138-147 DOI: 10.1111/ejh.13417
IF: 2,22 Q: 3
Valhondo I, Hassouneh F, Lopez-Sejas N, Pera A, Sanchez-Correa B, Guerrero B, Bergua JM, Arcos MJ, Banas H, Casas-Aviles I, Sanchez-Garcia J, Serrano J, Martin C, Duran E, Alonso C, Solana R, Tarazona R. Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia. CANCERS. 2020. 12 (8):- DOI: 10.3390/cancers12082171
IF: 6,126 Q: 1
Rodriguez-Pinilla SM, Domingo-Domenech E, Climent F, Sanchez J, Seoane CP, Jimenez JL, Garcia-Cosio M, Caballero D, Munez OJB, Carpio C, Castellvi J, Pozo AM, Farre BG, Bendana A, Aliste C, Gonzalez AJ, de Villambrosia SG, Piris MA, Codina JG, Mayordomo-A. Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study. BRITISH JOURNAL OF HAEMATOLOGY. 2020. 192 (1):82-99 DOI: 10.1111/bjh.16741
IF: 5,518 Q: 1
Gudiol C, Albasanz-Puig A, Laporte-Amargos J, Pallares N, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martin-Davila P, Herrera F, Gasch O, Drgona L, Morales HP, Brunel AS, Garcia E, Isler B, Kern WV, M. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2020. 64 (4):- DOI: 10.1128/AAC.02494-19
IF: 4,904 Q: 1
Vega-García N, Benito R, Esperanza-Cebollada E, Llop M, Robledo C, Vicente-Garces C, Alonso J, Barragan E, Fernandez G, Hernandez-Sanchez JM, Martin-Izquierdo M, Maynou J, Minguela A, Montano A, Ortega M, Torrebadell M, Cervera J, Sanchez J, Jimenez-Velasco A, Riesco S, Hernandez-Rivas JM, Lassaletta A, Fernandez JM, Rives S, Dapena JL, Ramirez M, Camos M. Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia. JOURNAL OF PERSONALIZED MEDICINE. 2020. 10 (4):- DOI: 10.3390/jpm10040244
IF: 4,433 Q: 1 D: 1
De Mier MVPR, Ojeda R, Alvarez-Lara MA, Navas A, Alonso C, Caballero-Villarraso J, Aljama P, Alvarez MA, Soriano S, Rodriguez M, Martin-Malo A. Hemodiafiltration with ultrafiltrate regeneration reduces free light chains without albumin loss in multiple myeloma patients. BMC NEPHROLOGY. 2020. 21 (1):227- DOI: 10.1186/s12882-020-01885-8
IF: 1,913 Q: 3
Serrano-Lopez J, Fernández JL, Lumbreras E, Serrano J, Martinez-Losada C, Martin C, Hernandez-Rivas JM, Sanchez-Garcia J. Machine learning applied to gene expression analysis of T-lymphocytes in patients with cGVHD. BONE MARROW TRANSPLANTATION. 2020. 55 (8):1668-1670 DOI: 10.1038/s41409-020-0848-y
IF: 4,725 Q: 1
Rodriguez-Medina C, Martínez-Cuadron D, Cano I, Gil C, Tormo M, Martinez-Sanchez MD, del Castillo TB, Serrano-Lopez J, Benavente C, Herrera-Puente P, Garcia-Boyero R, Lavilla-Rubira E, Amigo ML, Sayas-Llorisn MJ, Bergua-Burgues JM, Perez-Simon JA, Rodrigu. Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study. LEUKEMIA RESEARCH. 2020. 92 ():- DOI: 10.1016/j.leukres.2020.106352
IF: 2,214 Q: 3
Mira E, Yarce OA, Ortega C, Fernandez S, Pascual NM, Gomez C, Alvarez MA, Molina IJ, Lama R, Santamaria M. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2020. 8 (8):2793-2795 DOI: 10.1016/j.jaip.2020.06.046
IF: 7,574 Q: 1
Ribera JM, Garcia O, Chapchap EC, Gil C, Gonzalez-Campos J, Barba P, Amigo ML, Moreno MJ, Lavilla E, Alonso N, Bergua JM, Tormo M, Ribera J, Sierra M, Martinez-Carballeira D, Mercadal S, Hernandez-Rivas JM, Vall-Llovera F, Genesca E, Cladera A, Novo A, Ab. Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2020. 20 (8):E513-e522 DOI: 10.1016/j.clml.2020.03.011
IF: 2,298 Q: 3
Publicaciones 2019
Martinez-Cuadron D, Gil C, Serrano J, Rodriguez G, Perez-Oteyza J, Garcia-Boyero R, Jimenez-Bravo S, Vives S, Vidriales MB, Lavilla E, Perez-Simon JA, Tormo M, Colorado M, Bergua J, Lopez JA, Herrera P, Hernandez-Campo P, Gorrochategui J, Primo D, Rojas J; A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients. LEUKEMIA RESEARCH. 2019 Jan;76:1-10. doi: 10.1016/j.leukres.2018.11.006.
IF: 2,066 Q3
Sobas M, Montesinos P, Boluda B, Bernal T, Vellenga E, Nomdedeu J, Gonzalez-Campos J, Chillon M, Holowiecka A, Esteve J, Bergua J, Gonzalez-Sanmiguel JD, Gil-Cortes C, Tormo M, Salamero O, Manso F, Fernandez I, de la Serna J, Moreno MJ, Perez-Encinas M, K; An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens. LEUKEMIA & LYMPHOMA. 2019 Apr;60(4):1030-1035. doi: 10.1080/10428194.2018.1516875.
IF: 2,674 Q: 3
Megias-Vericat JE, Martinez-Cuadron D, Lopez JM, Bergua JM, Tormo M, Serrano J, Gonzalez A, de Oteyza JP, Vives S, Vidriales B, Herrera P, Vera JA, Martinez AL, de la Fuente A, Amador ML, Hernandez-Rivas JA, Fernandez MA, Cervero CJ, Morino D, Campo PH, G; Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES. 2019 Mar 1;11(1):e2019016. doi: 10.4084/MJHID.2019.016.
IF: 1,586 Q: 4
Garcia-Cadenas I, Yanez L, Jarque I, Martino R, Perez-Simon JA, Valcarcel D, Sanz J, Bermudez A, Munoz C, Calderon-Cabrera C, Garcia E, Alonso L, Suarez-Lledo M, Gonzalez Vicent M, Heras I, Viguria MC, Batlle M, Vazquez L, Lopez J, Solano C; Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH). EUROPEAN JOURNAL OF HAEMATOLOGY. 2019 Jun;102(6):465-471. doi: 10.1111/ejh.13226.
IF: 2,217 Q: 3
Alonso L, Gonzalez-Vicent M, Belendez C, Badell I, Sastre A, Rodriguez-Villa A, Bermudez-Cortes M, Hladun R, de Heredia CD; Hematopoietic stem cell transplantation in pediatric patients with thalassemia and sickle cell disease: An experience of the Spanish Working Group for Bone Marrow Transplantation in Children (GETMON). MEDICINA CLINICA. 2019 Feb 15;152(4):135-140. doi: 10.1016/j.medcli.2018.05.013.
IF: 1,277 Q: 3
Martos L, Fernandez-Pardo A, Lopez-Fernandez MF, Ibanez F, Herrero S, Tassies D, Gonzalez-Porras JR, Solmoirago MJ, Costa MJ, Reverter JC, Marco P, Roldan V, Lecumberri R, Velasco F, Oto J, Iruin G, Alonso MN, Vaya A, Bonanad S, Ferrando F, Marti E, Cid A; Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency. THROMBOSIS AND HAEMOSTASIS. 2019 Sep;119(9):1409-1418. doi: 10.1055/s-0039-1692440.
IF: 4,733 Q: 1
Albasanz-Puig A, Gudiol C, Parody R, Tebe C, Akova M, Araos R, Bote A, Brunel AS, Calik S, Drgona L, Garcia E, Hemmati P, Herrera F, Ibrahim KY, Isler B, Kanj S, Kern W, de la Calle GM, Manzur A, Marin JI, Marquez-Gomez I, Martin-Davila P, Mikulska M, Mon; Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study. BMJ OPEN. 2019 May 24;9(5):e025744. doi: 10.1136/bmjopen-2018-025744.
IF: 2,413 Q: 2
Ribera JM, Garcia O, Moreno MJ, Barba P, Garcia-Cadenas I, Mercadal S, Montesinos P, Barrios M, Gonzalez-Campos J, Martinez-Carballeira D, Gil C, Ribera J, Vives S, Novo A, Cervera M, Serrano J, Lavilla E, Abella E, Tormo M, Amigo ML, Artola MT, Genesca E; Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group. CANCER. 2019 Aug 15;125(16):2810-2817. doi: 10.1002/cncr.32156.
IF: 6,102 Q: 1
Revilla N, Corral J, Minano A, Mingot-Castellano ME, Campos RM, Velasco F, Gonzalez N, Galvez E, Berrueco R, Fuentes I, Gonzalez-Lopez TJ, de la Morena-Barrio ME, Gonzalez-Porras JR, Vicente V, Lozano ML; Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content. PLATELETS. 2019;30(6):743-751. doi: 10.1080/09537104.2018.1513476.
IF: 3,106 Q: 2
Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard J, Podoltsev NA, Brunner A, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germin; Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia. LEUKEMIA & LYMPHOMA. 2019 Jan;60(1):246-249. doi: 10.1080/10428194.2018.1468893.
IF: 2,674 Q: 3
Rodriguez-Veiga R, Montesinos P, Garcia E, Boluda B, Rojas R, Serrano J, Martinez-Cuadron D, Martin C, Sanz J, Tabares S, Pinana JL, Lorenzo I, Montoro J, Salavert M, Peman J, Jarque I, Solves P, Sanz GF, Torres A, Sanz MA; Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients. MYCOSES. 2019 May;62(5):418-427. doi: 10.1111/myc.12891.
IF: 3,065 Q: 2
Bento L, Bastida JM, Garcia-Cadenas I, Garcia-Torres E, Rivera D, Bosch-Vilaseca A, De Miguel C, Martinez-Munoz ME, Fernandez-Aviles F, Roldan E, Chinea A, Yanez L, Zudaire T, Vaz CP, Espigado I, Lopez J, Valcarcel D, Duarte R, Cabrera R, Herrera C, Gonza. Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant; Real life outcomes of patients aged >= 75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry. LEUKEMIA & LYMPHOMA. 2019 Nov;60(11):2720-2732. doi: 10.1080/10428194.2019.1607327.
IF: 2,674 Q: 3
Publicaciones 2018
Martinez-Losada C, Serrano-Lopez J, Serrano-Lopez J, Noguera NI, Garza E, Piredda L, Lavorgna S, Consalvo MAI, Ottone T, Alfonso V, Peinado JR, Garcia-Ortiz MV, Morales-Ruiz T, Jerez A, Hurtado AM, Montesinos P, Cervera J, Such E, Ibanez M, Sempere A, Sanz MA, Lo-Coco F, Sanchez-Garcia J. Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes. HAEMATOLOGICA. 2018; 103(9):E400-E403.
IF: 9,09 Q: 1 D: 1
Sanchez-Garcia J, Falantes J, Perez AM, Hernandez-Mohedo F, Hermosin L, Torres-Sabariego A, Bailen A, Hernandez-Sanchez JM, Rodriguez MS, Casano FJ, Calderon C, Labrador M, Vahi M, Serrano J, Lumbreras E, Hernandez-Rivas JM. Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia. LEUKEMIA & LYMPHOMA. 2018; 59(5):1095-1104.
IF: 2,644 Q: 2
Perez-Sanchez C, Arias-de la Rosa I, Aguirre MA, Luque-Tevar M, Ruiz-Limon P, Barbarroja N, Jimenez-Gomez Y, Abalos-Aguilera MC, Collantes-Estevez E, Segui P, Velasco F, Herranz MT, Lozano-Herrero J, Hernandez-Vidal MJ, Martinez C, Gonzalez-Conejero R, Radin M, Sciascia S, Cecchi I, Cuadrado MJ, Lopez-Pedrera C. Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome. HAEMATOLOGICA. 2018; 103(5):908-918.
IF: 9,09 Q: 1 D: 1
Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Majhail N, Barnard J, Podoltsev NA, Brunner AM, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Kobbe G, Bergua J, Serrano J, Gore SD, Zeidan AM. Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2018; 24(8):1754-1758.
IF: 4,484 Q: 1
de la Fuente FDA, Duran MS, Alvarez MA, Sanroman IL, Dios AM, Tamayo RR, Garcia R, Gonzalez MS, Prieto E, Barez A, Escalante F, Tejedor A, Ballesteros M, Cabanas V, Capote FJ, Couto C, Garzon S, Gonzalez-Pardo M, Manteca MVM. Subcutaneous bortezomib in newly diagnosed patients with multiple myeloma nontransplant eligible: Retrospective evaluation. SEMINARS IN HEMATOLOGY. 2018; 55(4):189-196.
IF: 3,926 Q: 2
Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard JD, Podoltsev NA, Brunner AM, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Fathi AT, Roboz GJ, Fenaux P, Litzow MR, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germing U, Bergua JM, Serrano J, Gore SD, Zeidan AM. Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort. BLOOD ADVANCES. 2018; 2(8):923-932.
Martinez-Cuadron D, Boluda B, Martinez P, Bergua J, Rodriguez-Veiga R, Esteve J, Vives S, Serrano J, Vidriales B, Salamero O, Cordon L, Sempere A, Jimenez-Ubieto A, Prieto-Delgado J, Diaz-Beya M, Garrido A, Benavente C, Perez-Simon JA, Moscardo F, Sanz MA, Montesinos P. A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia. ANNALS OF HEMATOLOGY. 2018; 97(5):763-772.
IF: 2,845 Q: 2
Serrano-Lopez J, Nattamai K, Pease NA, Shephard MS, Wellendorf AM, Sertorio M, Smith EA, Geiger H, Wells SI, Cancelas JA, Privette Vinnedge LM. 2.-Loss of DEK induces radioresistance of murine restricted hematopoietic progenitors. EXPERIMENTAL HEMATOLOGY 2018 Mar;59:40-50
IF: 2.436 Q: 2
Zhang C, D'Alessandro A, Wellendorf AM, Mohmoud F, Serrano-Lopez J, Perentesis JP, Komurov K, Alexe G, Stegmaier K, Whitsett JA, Grimes HL, Cancelas JA. 3.- KLF5 controls glutathione metabolism to suppress p190-BCR-ABL+ B-cell lymphoblastic leukemia. ONCOTARGET 2018 Jul 3;9(51):29665-29679.
IF: 3,45 Q: 2
Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard J, Podoltsev NA, Brunner A, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germing U, Bergua J, Serrano J, Gore SD, Zeidan AM. Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia. LEUK LYMPHOMA. 2019. Jan;60(1):246-249
IF: 2.644 Q: 2
